2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)

被引：0
|
作者：
S Yokota
T Imagawa
T Miyamae
K Kasai
M Mori
N Nishimoto
T Kishimoto
机构：
[1] Yokohama City University,
[2] Osaka University,undefined
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Corticosteroid; Respiratory Tract Infection; Juvenile Idiopathic Arthritis; Gastroenteritis; Tocilizumab;
D O I：
10.1186/1546-0096-6-S1-S1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Long Term Safety of Drugs in Systemic Juvenile Idiopathic Arthritis
    Gimenez, Ana Isabel Rebollo
    Carlini, Luca
    Miettunen, Paivi
    Alexeeva, Ekaterina
    Myrup, Charlotte
    Nicolai, Rebecca
    Trachana, Maria
    Stenevicha, Valda
    Ailioaie, Constantin
    Tsitsami, Elena
    Cochino, Alexis-Virgil
    Pallotti, Chiara
    Scala, Silvia
    Pistorio, Angela
    Vastert, Sebastiaan
    Swart, Joost
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 697 - 698
  • [32] Experience with Tocilizumab for Treatment of 56 Children with Systemic Juvenile Idiopathic Arthritis in the German JIA Biologics Register
    Horneff, Gerd
    Ganser, Gerd
    Haas, Johannes Peter
    Hospach, Toni
    Trauzeddel, Ralf
    Huppertz, Hans-Iko
    Kuemmerle-Deschner, J. B.
    Minden, Kirsten
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] EFFICACY AND SAFETY OF TOCILIZUMAB IN SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS - DATA OF THE BIKER REGISTRY
    Klein, Ariane
    Ganser, Gerd
    Trauzeddel, Ralf
    Minden, Kisten
    Rietschel, Christoph
    Kuemmerle-Deschner, Jasmin
    Horneff, Gerd
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 969 - 969
  • [34] Long-term evaluation of efficacy and safety of infliximab in the treatment of persistently active juvenile idiopathic arthritis (JIA), refractory to standard treatments
    Gerloni, V
    Pontikaki, I
    De Marco, G
    Valcamonica, E
    Gattinara, M
    Teruzzi, B
    Lurati, A
    Salmaso, A
    Fantini, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 515 - 515
  • [35] Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy
    Toplak, N.
    Avcin, T.
    VACCINE, 2015, 33 (33) : 4056 - 4059
  • [36] Efficacy and safety of an early response-based tapering regimen of tocilizumab in children with systemic juvenile idiopathic arthritis
    Dey, Soumya
    Roy, Debaditya
    Sinhamahapatra, Pradyot
    Ghosh, Alakendu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (05)
  • [37] HOW TOLERABLE IS METHOTREXATE IN THE LONG-TERM USE IN JUVENILE IDIOPATHIC ARTHRITIS (JIA)?
    Minden, K.
    Klotsche, J.
    Niewerth, M.
    Zink, A.
    Seipelt, E.
    Haas, J. -P.
    Ganser, G.
    Horneff, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 609 - 609
  • [38] Etanercept in treatment of juvenile idiopathic arthritis (JIA): Results of long-term study
    Calvo, I
    Ceballos, E
    Soriano, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 495 - 495
  • [39] Predictive Markers Of Joint Damages Of Children With Systemic-Onset Juvenile Idiopathic Arthritis In Long-Term Course Of Treatment With Tocilizumab
    Nozawa, Tomo
    Kanetaka, Taichi
    Nishimura, Kenichi
    Kikuchi, Masako
    Sato, Tomomi
    Sakurai, Nodoka
    Hara, Ryoki
    Yamazaki, Kazuko
    Yokota, Shumpei
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S113 - S113
  • [40] The long-term safety of etanercept in children with polyarticular or systemic juvenile rheumatoid arthritis
    Giannini, E. H.
    Llowite, N. T.
    Lovell, D. J.
    Wallace, C. A.
    Rabinovich, C. E.
    Reiff, A. O.
    Higgins, G.
    Chon, Y.
    Lin, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 550 - 550
12345